Fungal infection in the intensive care unit

Area of Science:

• Critical Care Medicine
• Mycology
• Infectious Diseases

Background:

• Fungal infections are a growing concern in critically ill patients.
• Candida species are the leading cause of these infections in intensive care units (ICUs).
• Risk factors include severe illness, prolonged antibiotic use, and intravascular catheters.

Purpose of the Study:

• To highlight the prevalence and diagnostic challenges of fungal infections in ICU patients.
• To discuss common causative agents and risk factors.
• To outline current diagnostic and treatment approaches.

Main Methods:

• Review of clinical presentation and diagnostic criteria for fungal infections in ICU settings.
• Analysis of common risk factors and predisposing conditions.
• Discussion of antifungal agents and treatment strategies.

Main Results:

• Clinical diagnosis is often difficult due to nonspecific signs and superficial colonization.
• Inferential evidence, such as persistent fever and elevated C-reactive protein, guides diagnosis.
• Amphotericin B and fluconazole are primary antifungal treatments, chosen based on fungal identity.

Conclusions:

• Fungal infections, particularly Candida, pose a significant threat to critically ill patients.
• Early and accurate diagnosis is crucial but challenging.
• Effective management involves risk factor identification and appropriate antifungal therapy.